About Adhisvar Pharmaceuticals Private Limited
Data last updated:
Adhisvar Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC101046. Its GSTIN is 24AAQCA5794C1ZH (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandip Nathubhai Mahajan and Udaykumar Jayantilal Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop 14 The Nest Apartments B/H Mother School Gotri R, Vadodara, Gujarat, India – 390019.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.85 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹36,064 (net margin 1.1%) and EBITDA of ₹65,680 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 13% over five years.
For more details, the company can be reached via its website adhisvarpharmaceutical.business.site.
Company details
Contact details
Adhisvar Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is adhisvarpharmaceutical.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop 14 The Nest Apartments B/H Mother School Gotri R, Vadodara, Gujarat, India – 390019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adhisvar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adhisvar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adhisvar Pharmaceuticals Private Limited, buy the company report.
Financials of Adhisvar Pharmaceuticals Private Limited
FY 2025 filings availableAdhisvar Pharmaceuticals Private Limited reported revenue of ₹33.85 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA rose 397% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹65,680 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36,064 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adhisvar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adhisvar Pharmaceuticals Private Limited
Adhisvar Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandip Nathubhai Mahajan | Director | 01 Mar 2018 | 8 Years 8 Months | Current |
| Udaykumar Jayantilal Patel | Director | 01 Mar 2018 | 8 Years 8 Months | Current |
| Shaileshbhai Ghanshyambhai Patel | Director | 01 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Adhisvar Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symbicure Pharmaceuticals Private Limited | ₹33.99 Lakh (FY 2024) | 41.0% | Vadodara, Gujarat, India | |||
| DMVM Drugs Private Limited | ₹33.98 Lakh (FY 2025) | 2420.0% | Delhi, India | |||
| Adhisvar Pharmaceuticals Private Limitedthis company | ₹33.85 Lakh (FY 2025) | ₹36,064 | 1.1% | -6.0% | Vadodara, Gujarat, India | |
| Nyla Pharmaceuticals Private Limited | ₹33.78 Lakh (FY 2024) | -24.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Adhisvar Pharmaceuticals Private Limited, buy the company report.
Auditor
Adhisvar Pharmaceuticals Private Limited is audited by SUKESH PATEL & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUKESH PATEL & ASSOCIATES | FY 2019 | 142364W |
Shareholding
The shareholding of Adhisvar Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Adhisvar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adhisvar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adhisvar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adhisvar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAQCA5794C1ZH | Gujarat | Active | 20 Mar 2018 |
To see the full GST registrations and return filing status of Adhisvar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Adhisvar Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Mayank Khandelwal ceased to be Additional Director on 25 Mar 2019.
Frequently asked questions
Adhisvar Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 March 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC101046.
Adhisvar Pharmaceuticals has 3 current directors:
- Sandip Nathubhai Mahajan - Director
- Udaykumar Jayantilal Patel - Director
- Shaileshbhai Ghanshyambhai Patel - Director
The latest financial statements of Adhisvar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Adhisvar Pharmaceuticals is 24AAQCA5794C1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Adhisvar Pharmaceuticals is U74999GJ2018PTC101046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adhisvar Pharmaceuticals was incorporated on 01 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Adhisvar Pharmaceuticals by revenue are Symbicure Pharmaceuticals Private Limited, DMVM Drugs Private Limited, Nyla Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayank Khandelwal ceased to be Additional Director on 25 Mar 2019. Sandip Nathubhai Mahajan was appointed as Director on 01 Mar 2018. Shaileshbhai Ghanshyambhai Patel was appointed as Director on 01 Mar 2018. Adhisvar Pharmaceuticals has 4 board changes on record in total.
Adhisvar Pharmaceuticals can be reached through the website adhisvarpharmaceutical.business.site. Its registered office is in Vadodara, Gujarat, India.
The registered office of Adhisvar Pharmaceuticals is at Shop 14 The Nest Apartments BH Mother School Gotri R, Vadodara, Gujarat, India – 390019.
Adhisvar Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
